Increased platelet CD36 constitutes a common marker in myeloproliferative disorders
- 1 November 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (3) , 618-624
- https://doi.org/10.1111/j.1365-2141.1995.tb05357.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Platelet activation results in a redistribution of glycoprotein IV (CD36).Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Analysis of CD36 Binding Domains: Ligand Specificity Controlled by Dephosphorylation of an EctodomainScience, 1993
- Nonatheromatous Arterial ThrombosisAnnual Review of Medicine, 1993
- Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donorsBritish Journal of Haematology, 1992
- Thrombospondin binds normally to glycoprotein IIIb deficient plateletsBiochemical and Biophysical Research Communications, 1991
- Interaction of a Monoclonal Antibody to Glycoprotein IV (CD36) with Human Platelets and its Effect on Platelet FunctionPlatelets, 1991
- Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor functionBritish Journal of Haematology, 1989
- Isolation of the thrombospondin membrane receptor.Journal of Clinical Investigation, 1987
- Essential thrombocythemias. Clinical evolutionary and biological dataCancer, 1986
- Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosisBritish Journal of Haematology, 1985